Aim: To report five children with posttraumatic orbital subperiosteal hematoma. Methods: In this study, five cases with posttraumatic orbital subperiosteal hematoma were studied and reviewed along with similar cases in a systematic literature review. Results: The mean age of our patients was 9.40 ± 3.51 years, ranging from 4 to 13 years, and all were male. Mechanisms of injuries were blunt trauma, falling from a building, car accident, and falling from a bicycle. All patients had unilateral involvement. Treatment options included needle aspiration, surgical drainage, and observation for spontaneous resolution. Except for one patient, positive outcomes were achieved. Conclusion: The most common location for posttraumatic orbital subperiosteal hematoma is the superior orbital wall. Traumatic optic neuropathy and permanent visual loss are uncommon. Observation, surgical drainage, and aspiration are common treatment options.
Thrombotic thrombocytopenic purpura (TTP) is a rare but fatal blood disorder characterized by microangiopathic hemolytic anemia, thrombocytopenia, and multi‐organ dysfunction. This condition often worsens during pregnancy and the postpartum period due to physiological changes. The present study reports a case of refractory TTP in a pregnant woman with a history of positive COVID‐19 infection who required aggressive treatment throughout her pregnancy and postpartum recovery. A 41‐year‐old pregnant woman (G3P2L2; C/S × 2) presented at 6 weeks of gestation with sudden hematuria, fever, and a positive COVID‐19 PCR test. Laboratory findings revealed the presence of schistocytes on the blood smear and a platelet count of 10,000/μL, strongly suggestive of TTP. Following hematology and gastroenterology evaluations, treatment was initiated immediately with methylprednisolone (1 mg/kg) and plasma exchange (PLEX). At 11 weeks of gestation, the patient's platelet count decreased to 12,000/μL, with evidence of hemolysis. She underwent eight sessions of PLEX and continued oral prednisolone therapy (1 mg/kg). The patient was subsequently discharged with a platelet count of 300,000/μL. Weekly outpatient PLEX and oral prednisolone were maintained throughout the pregnancy. At 36 weeks of gestation, the patient presented with labor pain and headache, leading to an emergency cesarean section. Postoperatively, she underwent 10 additional PLEX sessions and continued oral prednisolone treatment. She was discharged after 2 weeks in stable condition, without further complications. In conclusion, post‐COVID‐19 TTP could affect women and poses substantial therapeutic challenges. This case study highlights the complexities involved in managing refractory TTP during pregnancy and the postpartum period.